Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Autoimmune Disorders

Free Subscription 04.05.2026 3 BMC Neurol 1 Intern Med 3 J Autoimmun 2 J Immunol 3 J Neuroimmunol 4 J Neurol 1 Kidney Int 2 Lancet 6 Mult Scler 1 N Engl J Med 1 Neurologia (Engl Ed) 1 PLoS Comput Biol 4 PLoS One 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMC Neurol

1. CHEN H, Shi X, Huang Z, Li X, et al
   Co-occurrence of viral encephalitis and autoimmune encephalitis: overlapping peaks encephalitis or coincidence condition?
   BMC Neurol. 2026 Apr 29. doi: 10.1186/s12883-026-04926.
   PubMed        
   
   
2. SAWAFTAH MA, AbuBaha M, AbuBaha B, Shoman M, et al
   Infliximab-associated multifocal central nervous system demyelination mimicking multiple sclerosis in a patient with Crohn's disease: a case report.
   BMC Neurol. 2026 Apr 30. doi: 10.1186/s12883-026-04932.
   PubMed         Abstract available
   
   
3. SUN Y, Cao Z, Li F
   A case of novel meningoencephalomyelitis associated with vimentin IgG autoantibodies.
   BMC Neurol. 2026 Apr 27. doi: 10.1186/s12883-026-04912.
   PubMed        
   
   

   
   Intern Med

4. ANDO M, Fujikawa K, Matsuo H, Umetsu A, et al
   False-Positive Syphilis Serology Leading to the Diagnosis of Systemic Lupus Erythematosus: A Case Report.
   Intern Med. 2026 Apr 28. doi: 10.2169/internalmedicine.7273.
   PubMed         Abstract available
   
   

   
   J Autoimmun

5. LI Z, Li H, Tian B, Liu H, et al
   Free water in the hippocampal cingulum as a Radiomic biomarker for Identifying inflammatory neuropsychiatric Lupus: A cross-sectional case-control study.
   J Autoimmun. 2026;160:103560.
   PubMed         Abstract available
   
   
6. GAN Y, Liang W, Liu C, Yalavarthi S, et al
   Endothelial cell-derived plasminogen activator inhibitor-1 potentiates thrombosis in antiphospholipid syndrome.
   J Autoimmun. 2026;161:103563.
   PubMed         Abstract available
   
   
7. MORONI G, Uzzo M, Calatroni M, Conte E, et al
   Chronic kidney disease trajectories in lupus nephritis: Is progression unavoidable?
   J Autoimmun. 2026;161:103558.
   PubMed         Abstract available
   
   

   
   J Immunol

8. KHANDELWAL S, Chen J, Myoung SS, Lee GM, et al
   The influence of nuclear antigen form on complement activation by systemic lupus erythematosus antinuclear antibody immune complexes determined by a novel immunocapture assay.
   J Immunol. 2026;215:vkag088.
   PubMed         Abstract available
   
   
9. SHANG XY, Zhang R, Tan LG, Wang HY, et al
   The autoantibody beta1-AA contributes to N/OFQ-exacerbated ventricular arrhythmias following acute myocardial ischemia.
   J Immunol. 2026;215:vkag072.
   PubMed         Abstract available
   
   

   
   J Neuroimmunol

10. LV J, Liu J, Zhang L, Zhang Y, et al
    A novel circ_0018483/miR-4310/ERRFI1 ceRNA axis in myasthenia gravis.
    J Neuroimmunol. 2026;417:578938.
    PubMed         Abstract available
    
    
11. KARAMAN B, Goren G, Tuncel R, Ekmekci O, et al
    Successful treatment with eculizumab in refractory myasthenia gravis with both anti-AChR and anti-LRP4 antibodies: two case reports.
    J Neuroimmunol. 2026;417:578934.
    PubMed         Abstract available
    
    
12. IRIE KI, Imai T, Koga T, Tanaka Y, et al
    Combined inhibition of complement C5 and neonatal Fc receptor in refractory generalized myasthenia gravis: A report of two cases.
    J Neuroimmunol. 2026;417:578944.
    PubMed         Abstract available
    
    

    
    J Neurol

13. PASNOOR M, Miller-Wilson LA, Edwards Y, Copley-Merriman K, et al
    Burden of Disease in Myasthenia Gravis: A Targeted Literature Review.
    J Neurol. 2026;273:288.
    PubMed         Abstract available
    
    
14. IND G, Hashmi Z, Ahuja S, Fayad T, et al
    Demyelinating disorders in women: epidemiology, immunology, and clinical implications across MS, NMOSD, and MOGAD.
    J Neurol. 2026;273:290.
    PubMed         Abstract available
    
    
15. PENNER IK, Maier T, Wiemer T, Leemhuis J, et al
    Patient profiling in relapsing multiple sclerosis: insights from a real-world observational study into the unmet medical needs of patients on disease-modifying therapy.
    J Neurol. 2026;273:292.
    PubMed         Abstract available
    
    
16. TUOMAALA J, Saraste M, Smith E, Kuusi M, et al
    Association between post-COVID-19 neuropsychiatric symptoms and persistent glial activation in the limbic system: a TSPO PET study.
    J Neurol. 2026;273:298.
    PubMed         Abstract available
    
    

    
    Kidney Int

17. ROVIN BH, Furie R, Malvar A, Aranow C, et al
    Insights from the BLISS-LN Phase 3 study of biomarker associations with kidney response to belimumab in lupus nephritis.
    Kidney Int. 2026 Apr 27:S0085-2538(26)00307-8. doi: 10.1016/j.kint.2026.
    PubMed         Abstract available
    
    

    
    Lancet

18. VU T, Habib AA, Jacob S, Mantegazza R, et al
    Efficacy and safety of cemdisiran siRNA in myasthenia gravis (NIMBLE): a double-blind, randomised, placebo-controlled, phase 3 trial.
    Lancet. 2026 Apr 21:S0140-6736(26)00690-2. doi: 10.1016/S0140-6736(26)00690.
    PubMed         Abstract available
    
    
19. IORIO R
    Is partial complement blockade enough in myasthenia gravis?
    Lancet. 2026 Apr 21:S0140-6736(26)00749-X. doi: 10.1016/S0140-6736(26)00749.
    PubMed        
    
    

    
    Mult Scler

20. LEMBO F, Fantozzi R, Collura A, Buttari F, et al
    Cladribine in multiple sclerosis with autoimmune comorbidities: Further clinical insights from patients with rheumatologic disease treated in combination with secukinumab.
    Mult Scler. 2026 Apr 26:13524585261441504. doi: 10.1177/13524585261441504.
    PubMed        
    
    
21. PENG X, Bjornevik K, Clish CB, Edan G, et al
    Serum metabolic profile at clinical onset as predictor of multiple sclerosis activity and progression after 5 years.
    Mult Scler. 2026 Apr 26:13524585261435409. doi: 10.1177/13524585261435409.
    PubMed         Abstract available
    
    
22. HOLLEN C, Garcia C, Hemond CC, Spain RI, et al
    Filtered-phase imaging versus susceptibility-weighted imaging for paramagnetic rim lesion detection in multiple sclerosis: A head-to-head comparison.
    Mult Scler. 2026 Apr 26:13524585261439651. doi: 10.1177/13524585261439651.
    PubMed         Abstract available
    
    
23. GRECH L, Allan M, Skvarc D, Hamer R, et al
    Utility, validity, feasibility and acceptability of a clinician-administered depression, two-question screening tool for routine multiple sclerosis clinic administration.
    Mult Scler. 2026 Apr 26:13524585261435415. doi: 10.1177/13524585261435415.
    PubMed         Abstract available
    
    
24. SALTER A, Novak A, Lancia S, Cutter GR, et al
    Use of semaglutide and tirzepatide among people with multiple sclerosis.
    Mult Scler. 2026 Apr 29:13524585261442033. doi: 10.1177/13524585261442033.
    PubMed         Abstract available
    
    
25. GUARNASCHELLI MF, Marrodan M, Sosa BE, Perez Arana CI, et al
    Early use of high-efficacy disease-modifying therapies reduces the risk of progression independent of relapse and MRI activity in patients with relapsing-remitting multiple sclerosis.
    Mult Scler. 2026 Apr 29:13524585261442036. doi: 10.1177/13524585261442036.
    PubMed         Abstract available
    
    

    
    N Engl J Med

26. KAWANO N, Kikuchi I
    Membranoproliferative Glomerulonephritis Due to Cryoglobulinemia.
    N Engl J Med. 2026;394:1736.
    PubMed        
    
    

    
    Neurologia (Engl Ed)

27. GARCIA DOMINGUEZ JM, Maria Villar L, Arrambide G, Blanco Y, et al
    Relevance of serum neurofilament light chain determination as a biomarker in multiple sclerosis. Consensus of the Spanish Society of Neurology's Study Group on Multiple Sclerosis and Related Neuroimmune Diseases.
    Neurologia (Engl Ed). 2026;41:501928.
    PubMed         Abstract available
    
    

    
    PLoS Comput Biol

28. KOCKELBERGH H, Evans SC, Brierley L, Green PL, et al
    Evaluating the utility of amino acid similarity-aware kmers to represent TCR repertoires for classification.
    PLoS Comput Biol. 2026;22:e1014211.
    PubMed         Abstract available
    
    

    
    PLoS One

29. VILAR-LLUCH S, Knight D
    Type 1 and Type 2 diabetes in the UK press: A diachronic corpus-based analysis.
    PLoS One. 2026;21:e0348079.
    PubMed         Abstract available
    
    
30. FU Q, Li J, Gu X, Zhang Y, et al
    Artemether ameliorates type 1 diabetic liver injury alongside the associated defects in mitochondrial ultrastructure and central carbon metabolism.
    PLoS One. 2026;21:e0348214.
    PubMed         Abstract available
    
    
31. KWON C, Oh J, Shin HJ
    Comparative study of ocular and generalized myasthenia gravis in a South Korean cohort.
    PLoS One. 2026;21:e0346981.
    PubMed         Abstract available
    
    
32. WIDYASTUTI ESA, Lavina J, Darmajaya GJ, Sumantri S, et al
    Associated factors of health-related quality of life in Indonesian Women with Systemic Lupus Erythematosus: A cross-sectional within-cohort analysis.
    PLoS One. 2026;21:e0341989.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

33. HU W, Sun Y, Sun J, Liang Y, et al
    Cytochrome P450 1B1 directs pathogenic Th17 cell generation and autoimmune disease by fine-tuning redox homeostasis and mitochondrial integrity.
    Proc Natl Acad Sci U S A. 2026;123:e2527753123.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum